Elite in Hemophilia A

Elena M. Santagostino

Milan, IT 
Elite in Hemophilia A
Milan, IT 
OverviewLocationsClinical Research

Overview

Elena Santagostino practices in Milan, Italy. Ms. Santagostino is rated as an Elite expert by MediFind in the treatment of Hemophilia A. Her top areas of expertise are Blood Clots, Hemophilia A, Hemophilia B, Hemophilic Arthropathy, and Knee Replacement.

Her clinical research consists of co-authoring 183 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 155 articles and participated in 3 clinical trials in the study of Hemophilia A.

Gender
Female

Locations

Milan, Italy
Other Locations
Bianchi, Italy
Italy
Rome, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)
Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Biological
Study Drugs: PEG-Factor VIII, Eloctate ITI
Study Phase: Phase 3
A Phase 3, Multicenter, Open-label Study of the Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (BAX 802) in Subjects With Congenital Hemophilia A With Factor VIII Inhibitors Undergoing Surgical or Other Invasive Procedures
A Phase 3, Multicenter, Open-label Study of the Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (BAX 802) in Subjects With Congenital Hemophilia A With Factor VIII Inhibitors Undergoing Surgical or Other Invasive Procedures
Enrollment Status: Terminated
Publish Date: October 20, 2021
Intervention Type: Biological
Study Phase: Phase 3
Natural History Study of Factor IX Treatment and Complications
Natural History Study of Factor IX Treatment and Complications
Enrollment Status: Unknown
Publish Date: May 25, 2021
Intervention Type: Other
Study of Immunologic Determinants of Inhibitor Development in Previously Untreated Patients With Hemophilia
Study of Immunologic Determinants of Inhibitor Development in Previously Untreated Patients With Hemophilia
Enrollment Status: Completed
Publish Date: November 10, 2020
Intervention Type: Drug
View 3 Less Clinical Trials

183 Total Publications

A phase 1, open-label study to assess the pharmacokinetics, safety, and tolerability of a single intravenous injection of efanesoctocog alfa in adults with type 2N or type 3 von Willebrand disease.
A phase 1, open-label study to assess the pharmacokinetics, safety, and tolerability of a single intravenous injection of efanesoctocog alfa in adults with type 2N or type 3 von Willebrand disease.
Journal: Journal of thrombosis and haemostasis : JTH
Published: February 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Santagostino's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile